Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,647 total articles

Senate Hearing Puts 39% TV Ownership Cap at Center of Debate

Senate Hearing Puts 39% TV Ownership Cap at Center of Debate

A Senate Commerce Committee hearing will examine the long-standing national television ownership rule that prevents any broadcaster from reaching more than 39% of U.S. TV households. Testimony to be delivered includes a defense of the cap by Newsmax's CEO as a safeguard for competition and diversity, while the National Association of Broadcasters w…

Agomab Therapeutics Raises Roughly $200 Million in NASDAQ IPO

Agomab Therapeutics Raises Roughly $200 Million in NASDAQ IPO

Agomab Therapeutics NV completed an initial public offering that generated approximately $200 million in gross proceeds before underwriting fees and expenses. The clinical-stage Belgian biopharmaceutical firm sold 12.5 million American Depositary Shares at $16 apiece, began trading on February 6, 2026 under the ticker AGMB, and named a syndicate of…

Five Drone Stocks Poised for Attention in 2026, According to WarrenAI and Investing Pro Analysis

Five Drone Stocks Poised for Attention in 2026, According to WarrenAI and Investing Pro Analysis

WarrenAI and Investing Pro’s screening of performance metrics, technical indicators, and company-level developments highlights five publicly traded drone companies that stand out in 2026. The list spans established defense-focused firms and smaller, volatile players, each showing notable recent returns and specific catalysts ranging from government…

Target to Eliminate About 500 Roles to Shift Pay Toward Store Staffing

Target to Eliminate About 500 Roles to Shift Pay Toward Store Staffing

Target is reallocating personnel spending to strengthen in-store staffing after four years of flat annual sales. An internal memo says the company will eliminate roughly 500 positions across district and supply-chain functions and use the savings to increase payroll at its nearly 2,000 stores, expand hours where needed and roll out guest experience…

Mid-February Earnings Roundup: Coca-Cola, Gilead, Robinhood, Ford and More Headline Tuesday's Reports

Mid-February Earnings Roundup: Coca-Cola, Gilead, Robinhood, Ford and More Headline Tuesday's Reports

Earnings season presses on into the middle of February with a wide set of corporate reports due on Tuesday. Market attention will focus on several large-cap names spanning consumer staples, healthcare, financials and technology, with notable announcements from Coca-Cola, Gilead Sciences, Robinhood Markets, Ford Motor and American International Grou…

Kepler Cheuvreux Highlights BASF and Bayer as Top Picks in Chemicals Sector

Kepler Cheuvreux Highlights BASF and Bayer as Top Picks in Chemicals Sector

Kepler Cheuvreux’s latest sector review names BASF and Bayer as its leading recommendations within the chemicals industry, assigning both companies Buy ratings. The research underscores valuation upside for BASF and a potentially improving legal trajectory for Bayer, while noting ongoing operational and litigation headwinds that investors should mo…

NeuroSense Wins Australian Patent for PrimeC; Shares Tick Higher

NeuroSense Wins Australian Patent for PrimeC; Shares Tick Higher

NeuroSense Therapeutics saw its stock rise after the Australian Patent Office issued a patent covering its PrimeC extended-release oral therapy. The patent provides protection through October 2042 and complements an earlier U.S. patent as the company advances PrimeC toward Phase 3 testing in amyotrophic lateral sclerosis and pursues applications in…

Needham Sees Medtronic Poised for Stronger Organic Growth on New Product Wave and Activist-Led Oversight

Needham Sees Medtronic Poised for Stronger Organic Growth on New Product Wave and Activist-Led Oversight

Needham has upgraded Medtronic to Buy from Hold, arguing that a string of recent and upcoming product introductions across major markets, combined with activist involvement and board-level changes, should help accelerate organic revenue growth and improve execution over the next several years. The firm estimates new offerings could contribute more …